Innovent Biologics, Inc. (01801.HK) and Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced an exclusive license agreement for IBI355 (Spero R&D code: SP001), a third-generation Fc-silent ...
Under the terms of the agreement, Spero will receive exclusive global rights, excluding Greater China, to develop, research, manufacture, and commercialize SP001 (IBI355) Innovent will receive an ...
Summer weather inherently calls for wearing easy-going, lightweight dresses — and because we love a fashionable moment, all our pieces have to look incredibly chic, too. One of the easiest ways to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results